SECOND AMENDMENT TO LICENSE AGREEMENTLicense Agreement • December 17th, 2021 • Sonnet BioTherapeutics Holdings, Inc. • Pharmaceutical preparations
This SECOND AMENDMENT, dated as of July 7, 20121 (this “Second Amendment”), to the License Agreement, dated as of May 2, 2021 (the “Agreement”), is entered into by and between Sonnet Biotherapeutics CH SA (“Sonnet”), Sonnet Biotherapeutics, Inc. (“Guarantor”) and New Life Therapeutics PTE, Ltd (“New Life”). Unless otherwise set forth herein, capitalized terms used herein shall have the meanings set forth in the Agreement.
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • December 17th, 2021 • Sonnet BioTherapeutics Holdings, Inc. • Pharmaceutical preparations
This FIRST AMENDMENT, dated as of June 11, 20121 (this “First Amendment”), to the License Agreement, dated as of May 2, 2021 (the “Agreement”), is entered into by and between Sonnet Biotherapeutics, Inc. (“Sonnet”) and New Life Therapeutics PTE, Ltd (“New Life”). Unless otherwise set forth herein, capitalized terms used herein shall have the meanings set forth in the Agreement.
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. THE OMISSIONS HAVE BEEN INDICATED BY “[***]” Amendment to License Agreement...License Agreement • December 17th, 2021 • Sonnet BioTherapeutics Holdings, Inc. • Pharmaceutical preparations
This Amendment (the “Amendment”) to the License Agreement dated August 28th, 2015 between ARES TRADING SA and Sonnet BioTherapeutics CH SA (formerly Relief Therapeutics SA) (the “License Agreement”), is made and entered into as of the date last executed below, by
